| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |